

Table of Contents
ToggleIf you ask most Indian retail investors how they value a stock, you’ll hear the same answer: “I look at the P/E ratio.” And while the Price-to-Earnings ratio is a useful starting point, relying on it alone is like judging a book by its cover. You might miss the real story hidden underneath.
This is exactly why professional fund managers, institutional investors, and elite value investors around the world rely on a far more powerful metric: EV/EBITDA โ Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization.
Today, with the Sensex at 73,583 (down 1,690 points or 2.25% on March 27, 2026) and the Nifty at 22,820 amid geopolitical uncertainty from US-Iran tensions and Brent crude crossing $100/barrel, knowing how to properly value stocks is more important than ever. In volatile markets like this, the difference between a genuinely cheap stock and a value trap often comes down to using the right valuation metric.
Let’s break this metric into its two components so even a complete beginner can understand it.
Think of it this way: if you wanted to buy an entire company tomorrow โ lock, stock, and barrel โ what would it really cost you? That’s Enterprise Value.
EV = Market Capitalization + Total Debt โ Cash and Cash Equivalents
Why does this matter? Because Market Cap alone doesn’t tell you the full picture. Imagine two companies, both with a market cap of โน1,000 crore. Company A has zero debt and โน200 crore cash. Company B has โน500 crore debt and โน50 crore cash. Which one is truly more expensive to acquire? Company B, obviously โ because when you buy it, you also inherit its debt!
Same market cap, vastly different true cost. This is the power of Enterprise Value โ it captures the complete economic cost of owning a business.
EBITDA = Earnings Before Interest, Taxes, Depreciation, and Amortization
EBITDA strips away the noise of capital structure (debt vs. equity), tax regimes (which differ across states and countries), and accounting policies (depreciation methods vary wildly). What you’re left with is a clean measure of how much cash the core business operations generate.
This makes EBITDA the great equalizer โ it allows you to compare companies across industries, across capital structures, and even across countries on an apples-to-apples basis.
The P/E ratio completely ignores debt. A company with massive borrowings can have an artificially low P/E ratio because the earnings haven’t yet been destroyed by interest payments in a rising rate environment. EV/EBITDA captures the total capital structure, giving you the real picture.
This is especially critical in today’s Indian market where the RBI’s monetary policy and rising crude oil prices (Brent above $100) create interest rate uncertainty. Companies with heavy debt are far riskier than their P/E ratios suggest.
Two companies in the same industry can report very different “earnings” simply because of different depreciation methods, tax structures, or one-time items. EBITDA eliminates these distortions, showing you the raw operating power of the business.
A pharmaceutical company and a cement company have vastly different capital structures, tax rates, and depreciation policies. Comparing their P/E ratios is nearly meaningless. But comparing their EV/EBITDA gives you a genuine sense of which is cheaper relative to its cash-generating ability.
When Tata Group acquires a company, when Reliance makes a deal, when private equity firms evaluate targets โ they all use EV/EBITDA. Why? Because it tells them the true cost relative to the cash the business generates. If it’s good enough for billion-dollar deals, it’s good enough for your portfolio.
In sectors like infrastructure, telecom, cement, power, and manufacturing โ where companies have massive depreciation charges that suppress reported earnings โ the P/E ratio makes stocks look expensive when they’re actually cheap. EV/EBITDA corrects this distortion beautifully.
Here’s a practical guide for Indian investors:
| EV/EBITDA Range | Interpretation | Action |
|---|---|---|
| Below 8x | Potentially undervalued โ investigate further | Deep dive into why it’s cheap |
| 8x โ 12x | Fair value range for most sectors | Check growth prospects |
| 12x โ 20x | Premium valuation โ needs strong growth justification | Ensure quality matches price |
| Above 20x | Expensive โ only justified for exceptional compounders | Very high bar for quality |
Important caveat: These ranges vary by sector. Banking and financial companies should NOT be valued using EV/EBITDA (use P/B ratio instead). And high-growth tech companies may justifiably trade at higher multiples.
Understanding typical EV/EBITDA ranges for Indian sectors helps you identify outliers โ both opportunities and overvalued stocks:
Let’s apply this concept to a stock we know and follow closely โ Titan Biotech Ltd, currently trading around โน335-368 on the BSE, with an incredible 326% return over the past year.
Titan Biotech is a perfect example of why EV/EBITDA matters for small-cap investors. The company is virtually debt-free, sits on healthy cash reserves, and generates strong operating cash flows from its biotechnology products business. When you calculate its Enterprise Value, the absence of debt means the EV is actually lower than what you’d expect from the market cap alone โ because you subtract the cash!
This is the hallmark of a quality compounder: low debt, high cash generation, and an EV/EBITDA that reflects genuine value rather than financial engineering. When Manish Goel first identified Titan Biotech at around โน130, the EV/EBITDA was at compelling levels โ the market was pricing the stock as if its operating performance didn’t matter. Today’s 200%+ returns prove that the market eventually recognizes what EV/EBITDA reveals early.
You can calculate this for any Indian stock using freely available data from Screener.in or Tickertape:
Step 1: Find Market Capitalization โ Available on any financial website. Current share price ร total number of shares.
Step 2: Add Total Debt โ Found in the Balance Sheet under “Borrowings” (both short-term and long-term).
Step 3: Subtract Cash โ Found in the Balance Sheet as “Cash and Cash Equivalents” plus “Bank Balances.”
Step 4: Calculate EV โ Market Cap + Total Debt โ Cash = Enterprise Value.
Step 5: Find EBITDA โ Either reported directly, or calculate it: Operating Profit (EBIT) + Depreciation + Amortization. Available in the Profit & Loss statement.
Step 6: Divide โ EV รท EBITDA = Your EV/EBITDA multiple.
Step 7: Compare โ Compare this number against the sector averages listed above and against the company’s own historical range.
Financial companies earn money from the spread between borrowing and lending rates. Debt IS their business, not a liability in the traditional sense. Use Price-to-Book (P/B) ratio for banks, not EV/EBITDA.
EBITDA doesn’t account for capital expenditure needed to maintain the business. A steel plant or a telecom tower company may show great EBITDA but require massive capex just to stay operational. Always check EBITDA minus Capex for the full picture.
Always look at the 3-year or 5-year average EV/EBITDA trend. A cyclical company at peak earnings will have a deceptively low EV/EBITDA that can mislead you into buying at the top of the cycle.
An IT company at 20x EV/EBITDA may be cheaper than a cement company at 12x EV/EBITDA when you factor in growth rates, margins, and return ratios. Always compare within the same sector first.
When you find a stock with an attractive EV/EBITDA, run through this checklist before investing:
โ Is the low EV/EBITDA structural or temporary? โ Structural means the market is mispricing a quality business. Temporary means earnings are at a cyclical peak and about to decline.
โ Is the company generating real free cash flow? โ EBITDA means nothing if the cash isn’t actually flowing into the company’s bank account.
โ What’s the trend? โ Is EV/EBITDA contracting (getting cheaper) or expanding (getting expensive)?
โ How does it compare to peers? โ A company trading at 8x when peers trade at 15x deserves investigation.
โ Is management quality high? โ Even the cheapest valuation won’t save you from dishonest or incompetent management.
With the Sensex losing 1,690 points today and markets gyrating on crude oil and geopolitical fears, many stocks are becoming cheaper on a headline basis. But are they genuinely cheaper? Only EV/EBITDA (combined with other quality metrics) can tell you.
SEBI’s data shows that over 90% of F&O traders lose money. These traders chase momentum, technical patterns, and tips โ they never bother to understand what they’re buying. As value investors, our edge comes from understanding the true worth of a business better than the market does. EV/EBITDA is one of the most powerful tools in that arsenal.
Instead of gambling in Futures & Options where 9 out of 10 traders destroy their capital, learn to use professional valuation metrics like EV/EBITDA to build lasting wealth through quality stock picking. The free Value Investing Course by Manish Goel covers these concepts in depth โ available in both English and Hindi.
โ EV/EBITDA captures the true cost of a business relative to its operating cash generation โ something P/E ratio misses completely.
โ It accounts for debt, cash, and capital structure differences โ making it the gold standard for comparing companies.
โ In today’s volatile Indian market (Nifty 22,820, crude above $100), using EV/EBITDA helps you separate genuine bargains from value traps.
โ Quality compounders like Titan Biotech (BSE: 524717, up 326% in one year) often show their true value through EV/EBITDA before the market catches on.
โ Never use EV/EBITDA for banks/NBFCs, and always combine it with free cash flow analysis and management quality assessment.
Disclaimer: This article is for educational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult a SEBI-registered investment advisor before making any investment decisions. The author Manish Goel holds positions in Titan Biotech Ltd (BSE: 524717). Past performance does not guarantee future returns.
๐ข Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates โ delivered straight to your phone!
โ๏ธ Join @longtermequityy on Telegram
๐ Free โข No spam โข Value investing insights daily
Chat with us on WhatsApp